Berbari Elie F, Marculescu Camelia, Sia Irene, Lahr Brian D, Hanssen Arlen D, Steckelberg James M, Gullerud Rachel, Osmon Douglas R
Section of Orthopedic infectious Diseases, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Clin Infect Dis. 2007 Nov 1;45(9):1113-9. doi: 10.1086/522184. Epub 2007 Sep 26.
Culture-negative (CN) prosthetic joint infection (PJI) has not been well studied. We performed a retrospective cohort study to define the demographic characteristics and determine the outcome of patients with CN PJI.
All cases of CN total hip arthroplasty and total knee arthroplasty infections (using a strict case definition) treated at our institution from January 1990 through December 1999 were analyzed. Kaplan-Meier survival methods were used to determine the cumulative probability of success.
Of 897 episodes of PJI during the study period, 60 (7%) occurred in patients for whom this was the initial episode of CN PJI. The median age of the cohort was 69 years (range, 36-87 years). Patients had received a prior course of antimicrobial therapy in 32 (53%) of 60 episodes. Of the 60 episodes, 34 (57%), 12 (20%), and 8 (13%) were treated with 2-stage exchange, debridement and retention, and permanent resection arthroplasty, respectively. The median duration of parenteral antimicrobial therapy was 28 days (range, 0-88 days). Forty-nine (82%) of 60 episodes were treated with a cephalosporin. The 5-year estimate of survival free of treatment failure was 94% (95% confidence interval, 85%-100%) for patients treated with 2-stage exchange and 71% (95% confidence interval, 44%-100%) for patients treated with debridement and retention.
CN PJI occurs infrequently at our institution. Prior use of antimicrobial therapy is common among patients with CN PJI. CN PJI treated at our institution is associated with a rate of favorable outcome that is comparable to that associated with PJI due to known bacterial pathogens.
培养阴性(CN)的人工关节感染(PJI)尚未得到充分研究。我们进行了一项回顾性队列研究,以确定人口统计学特征并确定CN PJI患者的治疗结果。
分析了1990年1月至1999年12月在我们机构接受治疗的所有CN全髋关节置换术和全膝关节置换术感染病例(采用严格的病例定义)。采用Kaplan-Meier生存方法确定成功的累积概率。
在研究期间的897例PJI发作中,60例(7%)发生在初次出现CN PJI的患者中。该队列的中位年龄为69岁(范围36 - 87岁)。60例发作中有32例(53%)患者曾接受过抗菌治疗。在这60例发作中,分别有34例(57%)、12例(20%)和8例(13%)接受了两阶段翻修、清创保留和永久性切除关节成形术治疗。肠外抗菌治疗的中位持续时间为28天(范围0 - 88天)。60例发作中有49例(82%)接受了头孢菌素治疗。接受两阶段翻修治疗的患者无治疗失败的5年生存率估计为94%(95%置信区间,85% - 100%),接受清创保留治疗的患者为71%(95%置信区间,44% - 100%)。
CN PJI在我们机构中很少见。先前使用抗菌治疗在CN PJI患者中很常见。在我们机构接受治疗的CN PJI的良好结局发生率与已知细菌病原体导致的PJI相当。